Patent Pools and Standard Setting in Diagnostic Genetics  

Oleh:

Ebersole, Ted J. ; Guthrie, Marvin C.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 8 (Agu. 2005), page 937-938.
Topik: GENETICS; patent pools; diagnostic genetics

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.4 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Properly structured and implemented, diagnostic patent pools could integrate complementary technologies, reduce transaction costs and spur innovation. Genetic diseases often involve multiple henes and / or gene fragments that are patented, along with diagnostic methods and microprocessing arrays. Potential roadblocks to the accessibility of present and new genetic testing technologies can result from : i. patentees exercising technology by anyone other then themselves of their exclusive licences (exclusivity), and ii. the need to acquire multiple licenses to an ever increasing number patents owned by different patentees (stacking) Several solutions have been proposed to address the concerns arising from the patenting of diagnostic genetic tests. For example, it has been proposed that the US Patent and Trademark Office apply the existing statutory requirements for patentability more stringently to the field of genomics, or that the court of appeals for the federal circuit, the most specialized patent court in the US, apply its nonobviousness standards as stringently to human gene patents as it does to other advancing fields of technology...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali